Twitchell W A, Rane S G
Department of Biological Sciences, Purdue University, West Lafayette, Indiana 47907.
Mol Pharmacol. 1994 Nov;46(5):793-8.
Physiological responses to opiates and opioid peptides are transduced via receptors coupled to G proteins. The effectors for these G proteins are often ion channels or second messenger systems that modulate channel activity. In cultured bovine adrenal medullary chromaffin cells (BAMCCs), the activity of a calcium-dependent, voltage-sensitive, potassium (BK) channel is robustly potentiated by a mu-type opioid receptor, an effect consistent with the inhibitory role of opioids versus neural excitability. Patch-clamp electrophysiology was used to investigate coupling between the mu receptor and BK channel, leading to rather surprising results. Potentiation of BK channel activity by the mu-selective agonist [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin (10 nM) was unaffected by all attempts to disrupt or alter G protein function, including incubation of cells with pertussis toxin (PTX) and inclusion of guanosine 5'-O-(2-thio)diphosphate (GDP beta S) or guanosine 5'-O-(3-thio)triphosphate (GTP gamma S) in intracellular recording solutions. However, dopamine D2 receptor potentiation of BK current in these same cells was affected by PTX, GDP beta S, and GTP gamma S in predictable fashion. Thus, PTX and GDP beta S inhibited dopamine potentiation of BK current, and GTP gamma S prolonged reversal of dopamine action. These results suggest that the BAMCC BK channel is not coupled to the mu receptor via a GTP-dependent mechanism, whereas in the same cells the dopamine D2 receptor modulates BK channel activity in a conventional GTP-dependent manner. In addition, replacement of both ATP and GTP with nonhydrolyzable analogs also failed to affect either potentiation or recovery of BK channel activity in response to [D-Ala2,N-Me-Phe4,Gly5-ol]-enkephalin. These results indicate that in BAMCCs the mu-opioid receptor modulates BK channel activity independently of either G proteins or phosphorylation-dependent processes.
对阿片类药物和阿片样肽的生理反应是通过与G蛋白偶联的受体来传导的。这些G蛋白的效应器通常是离子通道或调节通道活性的第二信使系统。在培养的牛肾上腺髓质嗜铬细胞(BAMCCs)中,钙依赖性、电压敏感性钾(BK)通道的活性被μ型阿片受体强烈增强,这一效应与阿片类药物对神经兴奋性的抑制作用一致。采用膜片钳电生理学方法研究μ受体与BK通道之间的偶联,结果令人相当惊讶。μ选择性激动剂[D-Ala2,N-Me-Phe4,Gly5-ol]-脑啡肽(10 nM)对BK通道活性的增强不受任何破坏或改变G蛋白功能尝试的影响,包括用百日咳毒素(PTX)孵育细胞以及在细胞内记录溶液中加入鸟苷5'-O-(2-硫代)二磷酸(GDPβS)或鸟苷5'-O-(3-硫代)三磷酸(GTPγS)。然而,这些相同细胞中多巴胺D2受体对BK电流的增强受到PTX、GDPβS和GTPγS的影响,且符合预期模式。因此,PTX和GDPβS抑制了多巴胺对BK电流的增强作用,而GTPγS延长了多巴胺作用的反转。这些结果表明,BAMCC BK通道并非通过GTP依赖性机制与μ受体偶联,而在相同细胞中,多巴胺D2受体以传统的GTP依赖性方式调节BK通道活性。此外,用不可水解类似物替代ATP和GTP也未能影响[D-Ala2,N-Me-Phe4,Gly5-ol]-脑啡肽引起的BK通道活性增强或恢复。这些结果表明,在BAMCCs中,μ阿片受体独立于G蛋白或磷酸化依赖性过程来调节BK通道活性。